WordNet

a heavy precious metallic element; grey-white and resistant to corroding; occurs in some nickel and copper ores and is also found native in some deposits (同)Pt, atomic number 78

PrepTutorEJDIC

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 上皮性卵巣癌、卵管癌、または腹膜癌の再発に対する薬物療法：プラチナ製剤抵抗性癌 medical treatment for relapsed epithelial ovarian fallopian tubal or peritoneal cancer platinum resistant disease
2. 上皮性卵巣癌、卵管癌、または腹膜癌の再発に対する薬物療法：プラチナ製剤感受性癌 medical treatment for relapsed epithelial ovarian fallopian tubal or peritoneal cancer platinum sensitive disease
3. プラチナベースの化学療法の神経学的合併症の概要 overview of neurologic complications of platinum based chemotherapy
4. 上皮性卵巣癌、卵管癌、または腹膜癌における血管新生阻害剤の作用 the role of angiogenesis inhibitors in epithelial carcinoma of the ovary fallopian tube or peritoneum
5. 転移性および再発性頭頚部癌の治療 treatment of metastatic and recurrent head and neck cancer

Unprecedented water addition to the α,β-unsaturated enone bond, mediated by the combination of carbonate and platinum(II).

Marqués-Gallego P, Reedijk J.SourceLeiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, PO Box 9502, 2300 RA Leiden, The Netherlands.
Chemistry (Weinheim an der Bergstrasse, Germany).Chemistry.2010 Nov 15;16(43):12860-4.
The cytostatic compounds cis-[Pt(A9pyp)(dmso)Cl(2)] (1) and [Pt(A9pyp)(dmso)(cbdca)] (2) (A9pyp=(E)-[1-(9-anthryl)-3-(2-pyridyl)-2-propenone) as carrier ligand; cbdca=cyclobutane dicarboxylate) have been found to add water across the enone C==C bond of the ligand A9pyp. The water addition occurs in
PMID 20878801

Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.

Liu W, Chen X, Xie M, Lou L, Ye Q, Yu Y, Hou S.SourcePlatinum-Based Drug Lab, Kunming Institute of Precious Metals, Kunming 650106, PR China. liuweiping0917@126.com
Journal of inorganic biochemistry.J Inorg Biochem.2008 Oct;102(10):1942-6. Epub 2008 Jul 11.
A series of novel platinum(II) complexes involving a carrier with HO- peripheral functional group, 2-hydroxy-1,3-propanediamine (HO-pda), cis-[Pt(HO-dpa)X(2)] (X(2)=2Cl(-) (1), C(2)O(4)(2-) (2), malonate (3), 1,1-cyclobutane dicarboxylate (CBDCA) (4), 3-hydroxy-1,1-cyclobutanedicarboxylate (HO-CBDCA
PMID 18707762